FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Tailstorm Health INC | 81483-0049 | 81483-0049-4 | SEMAGLUTIDE | SEMAGLUTIDE | 2.4 mg/.3 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0046 | 81483-0046-4 | SEMAGLUTIDE | SEMAGLUTIDE | .5 mg/.1 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0052 | 81483-0052-4 | Tirzepatide | Tirzepatide | 7.5 mg/.3 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0055 | 81483-0055-4 | Tirzepatide | Tirzepatide | 15 mg/.3 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0054 | 81483-0054-4 | Tirzepatide | Tirzepatide | 12.5 mg/.25 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0051 | 81483-0051-4 | Tirzepatide | Tirzepatide | 5 mg/.2 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0050 | 81483-0050-4 | Tirzepatide | Tirzepatide | 2.4 mg/.1 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0053 | 81483-0053-4 | Tirzepatide | Tirzepatide | 10 mg/.2 mL | 2024-2 | valid | 2026-09-18 | |
| The Ritedose Corporation | 837769546 | 65302-506 | 65302-506-10 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2024-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-505 | 65302-505-10 | Phenylephrine Hydrochloride | 80 ug/1 mL | 2024-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-510 | 65302-510-05 | Rocuronium Bromide | 10 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-504 | 65302-504-05 | Succinylcholine Chloride | 20 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-504 | 65302-504-10 | Succinylcholine Chloride | 20 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-507 | 65302-507-10 | Epinephrine | .1 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-503 | 65302-503-04 | Labetalol Hydrochloride | 5 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-526 | 65302-526-10 | Lidocaine Hydrochloride | 10 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-508 | 65302-508-35 | Atropine Sulfate | .4 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-501 | 65302-501-05 | Neostigmine Methylsulfate | 1 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 65302-508 | 65302-508-35 | Atropine Sulfate | Atropine Sulfate | .4 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| The Ritedose Corporation | 65302-507 | 65302-507-10 | Epinephrine | Epinephrine | .1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| The Ritedose Corporation | 65302-503 | 65302-503-04 | Labetalol Hydrochloride | Labetalol Hydrochloride | 5 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| The Ritedose Corporation | 65302-526 | 65302-526-10 | Lidocaine Hydrochloride 1% | Lidocaine Hydrochloride 1% | 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| The Ritedose Corporation | 65302-501 | 65302-501-05 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | 1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| The Ritedose Corporation | 65302-506 | 65302-506-10 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 100 ug/1 mL | 2024-2 | valid | 2026-09-18 | |
| The Ritedose Corporation | 65302-505 | 65302-505-10 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 80 ug/1 mL | 2024-2 | valid | 2026-09-18 | |
| The Ritedose Corporation | 65302-510 | 65302-510-05 | Rocuronium Bromide | Rocuronium Bromide | 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| The Ritedose Corporation | 65302-504 | 65302-504-05 | Succinylcholine Chloride | Succinylcholine Chloride | 20 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| The Ritedose Corporation | 65302-504 | 65302-504-10 | Succinylcholine Chloride | Succinylcholine Chloride | 20 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Turbare Manufacturing | 118984002 | 83556-0101 | 83556-0101-1 | Bevacizumab | 1.25 mg/.05 mL | 2024-2 | valid | 2026-11-08 | |
| Turbare Manufacturing | 83556-0101 | 83556-0101-1 | Avastin 1.25mg/0.05mL | Repackaged Avastin 1.25mg/0.05mL | 1.25 mg/.05 mL | 2024-2 | valid | 2026-09-18 | |
| US Specialty Formulations LLC | 079181064 | 69389-064 | 69389-064-22 | Sarracenia Purpurea | 5 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| US Specialty Formulations LLC | 69389-064 | 69389-064-22 | Sarracenia Purpurea | Sarracenia Purpurea | 5 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Wedgewood Connect | 079215020 | 79926-068 | 79926-068-05 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| Wedgewood Connect | 79926-068 | 79926-068-05 | Moxifloxacin | Moxifloxacin | 1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Wells Pharma of Houston | 055774114 | 73702-146 | 73702-146-61 | Nicotinamide Riboside Chloride | 500 mg/5 mL | 2024-2 | valid | 2026-11-08 | |
| Wells Pharma of Houston | 055774114 | 73702-144 | 73702-144-60 | Nicotinamide Riboside Chloride | 100 mg/5 mL | 2024-2 | valid | 2026-11-08 | |
| Wells Pharma of Houston | 73702-144 | 73702-144-60 | Nicotinamide Riboside Chloride 100 mg | Nicotinamide Riboside Chloride 100 mg | 100 mg/5 mL | 2024-2 | valid | 2026-09-18 | |
| Wells Pharma of Houston | 73702-146 | 73702-146-61 | Nicotinamide Riboside Chloride 500 mg | Nicotinamide Riboside Chloride 500 mg | 500 mg/5 mL | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-056 | 70713-056-01 | ESTRADIOL 10MG | ESTRADIOL 10MG | 10 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-051 | 70713-051-01 | ESTRADIOL 12.5MG | ESTRADIOL 12.5MG | 12.5 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-148 | 70713-148-01 | ESTRADIOL 12.5MG | ESTRADIOL 12.5MG | 12.5 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-144 | 70713-144-01 | ESTRADIOL 18MG | ESTRADIOL 18MG | 18 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-145 | 70713-145-01 | ESTRADIOL 20MG | ESTRADIOL 20MG | 20 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-131 | 70713-131-01 | ESTRADIOL 25MG | ESTRADIOL 25MG | 25 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-050 | 70713-050-01 | ESTRADIOL 6MG | ESTRADIOL 6MG | 6 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-026 | 70713-026-01 | PROGESTERONE SA2 100MG | PROGESTERONE SA2 100MG | 100 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-036 | 70713-036-01 | PROGESTERONE SA2 50MG | PROGESTERONE SA2 50MG | 50 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-043 | 70713-043-01 | TESTOSTERONE ANASTROZOLE SA2 100MG 4MG | TESTOSTERONE ANASTROZOLE SA2 100MG 4MG | 100 mg; 4 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-014 | 70713-014-01 | TESTOSTERONE ANASTROZOLE SA2 200MG 20MG | TESTOSTERONE ANASTROZOLE SA2 200MG 20MG | 200 mg; 20 mg | 2024-2 | valid | 2026-09-18 | |
| Wells Pharmacy, Inc | 70713-034 | 70713-034-01 | TESTOSTERONE ANASTROZOLE SA2 200MG 8MG | TESTOSTERONE ANASTROZOLE SA2 200MG 8MG | 200 mg; 8 mg | 2024-2 | valid | 2026-09-18 |